CUE 10-Q: SEC filing

Cue Biopharma

Filed with the SEC on · accession 0001193125-26-463755

CUE filed a 10-Q (quarterly report) with the SEC on Nov 16, 2026. Cue Biopharma filed its Q3 2026 10-Q, reporting ongoing collaboration and license agreements, a term loan with Silicon Valley Bank, and various equity and warrant transactions. The stock moved -12.5% by the first close after the filing.

Summary of the filing

Cue Biopharma filed its Q3 2026 10-Q, reporting ongoing collaboration and license agreements, a term loan with Silicon Valley Bank, and various equity and warrant transactions. The filing reflects routine quarterly financial reporting with no single major corporate event.

Key details

FilerCue Biopharma, Inc.
LenderSilicon Valley Bank
Collaboration and license partnerImmunoScape Pte Ltd
License and service agreement counterpartyAlbert Einstein College of Medicine
Transaction expense counterpartyJefferies LLC

How CUE stock reacted

Close before

$16.12

Nov 13, 2026

First close after

-12.53%

$14.10

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for CUE, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for CUE?

Click here

Frequently asked questions

What did CUE file with the SEC on Nov 16, 2026?

CUE filed a 10-Q (SEC filing). Cue Biopharma filed its Q3 2026 10-Q, reporting ongoing collaboration and license agreements, a term loan with Silicon Valley Bank, and various equity and warrant transactions. The filing reflects routine quarterly financial reporting with no single major corporate event.

How do I read a 10-Q?

The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.

How did CUE stock react to this filing?

CUE closed at $16.12 before the filing and $14.10 on Nov 16, 2026 (-12.53%).

Other CUE SEC filings

Get alerts when CUE files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days